Results 211 to 220 of about 41,304 (260)

Long and Massive Thrombus in the Left Coronary Artery: A Case of Acute Myocardial Infarction Treated Using Immediate Stenting and Direct Oral Anticoagulant Plus Dual Antiplatelet Therapy. [PDF]

Case Rep Cardiol
Honda N, Inanaga K, Nishi JI, Inoue S.
europepmc   +1 more source

Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection. [PDF]

J Gastroenterol
Ono Y, Hatta W, Tarasawa K, Ogata Y, Abe H, Sato I, Hatayama Y, Saito M, Jin X, Uno K, Koike T, Imatani A, Hamada S, Fujimori K, Fushimi K, Masamune A.   +15 more
europepmc   +1 more source

Clinical outcomes with the use of aspirin vs. clopidogrel as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation. [PDF]

Eur Heart J Cardiovasc Pharmacother
Kim S, Park S, Kim H, Aung N, Kim SH, Chang K, Choi Y.   +6 more
europepmc   +1 more source

Plain language summary of the direct oral anticoagulant switch study: effect of switching or continuing apixaban or rivaroxaban among people with non-valvular atrial fibrillation. [PDF]

Future Cardiol
Deitelzweig S, Jiang J, Subash R, Cheng D, Lip GYH.   +4 more
europepmc   +1 more source

Increased direct oral anticoagulant use and event rates in non-valvular atrial fibrillation: a nationwide retrospective registry study in Sweden. [PDF]

BMJ Open
Kadhim H, Jansson M, Själander S, Sjögren V, Björck F, Renlund H, Eriksson M, Norrving B, Själander A.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Direct oral anticoagulants: An update

Medicina Clínica (English Edition), 2018
Vitamin K antagonists were the only choice for chronic oral anticoagulation for more than half a century. Over the past few years, direct oral anticoagulants have emerged, including one direct thrombin inhibitor (dabigatran etexilate) and three factor Xa inhibitors (apixaban, edoxaban and rivaroxaban).
Ana Isabel, Franco Moreno, Rosa María, Martín Díaz, María José, García Navarro   +2 more
openaire   +2 more sources

Edoxaban: A direct oral anticoagulant

American Journal of Health-System Pharmacy, 2017
The pharmacology, pharmacokinetics, pharmacodynamics, clinical efficacy, safety, and place in therapy of edoxaban for prevention of stroke in patients with nonvalvular atrial fibrillation (AF) and treatment of venous thromboembolism (VTE) are reviewed.Although warfarin has been an established therapy for stroke prevention in AF and VTE, the need for ...
Mara, Poulakos, Jacqueline N, Walker, Umima, Baig, Tosin, David   +3 more
openaire   +2 more sources